FINANCIAL NEWS

Saudi pharma market to grow 4.7% annually: Deloitte

05 Jan 2013

(MENAFN) Deloitte issued a report that says that the Saudi pharmaceutical market would stand at the value of USD4.7 billion after three years, reported Saudi Gazette.

Deloitte explained that an annual 4.7 percent growth rate would lead to this growth by 2016.

Deloitte cited this growth to increase in population, government spending and the increasing interest in this market.

It is worth mentioning that the Saudi pharmaceutical market is one of the largest among Middle Eastern Countries.

More News

This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more